Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest
Mahban Rahimifard, Maryam Baeeri, Taraneh Mousavi, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 18

Showing 18 citing articles:

Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways
Lianli Ni, Xinping Zhu, Qi Zhao, et al.
Neoplasia (2024) Vol. 51, pp. 100991-100991
Open Access | Times Cited: 5
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Songting Shou, Ayidana Maolan, Di Zhang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Therapeutic effects of quercetin in oral cancer therapy: a systematic review of preclinical evidence focused on oxidative damage, apoptosis and anti-metastasis
Mohamed J. Saadh, Hanan Hassan Ahmed, Muktesh Chandra, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Antitumor Effects of Resveratrol Opposing Mechanisms of Helicobacter pylori in Gastric Cancer
D. Trautmann, Francesca Suazo, Keila Torres, et al.
Nutrients (2024) Vol. 16, Iss. 13, pp. 2141-2141
Open Access | Times Cited: 4
Cisplatin and Procaterol Combination in Gastric Cancer? Targeting Checkpoint Kinase 1 for Cancer Drug Discovery and Repurposing by an Integrated Computational and Experimental Approach
S Prema, Jaikanth Chandrasekaran, Saptami Kanekar, et al.
OMICS A Journal of Integrative Biology (2024) Vol. 28, Iss. 1, pp. 8-23
Closed Access | Times Cited: 2
Modulating oxidative stress, apoptosis, and mitochondrial dysfunctions on cardiotoxicity induced by aluminum phosphide pesticide using resveratrol
Deema Kamal Sabir, Abeer A. Al‐Masri, Munirah F. Aldayel, et al.
Toxicology Mechanisms and Methods (2024) Vol. 34, Iss. 6, pp. 727-735
Closed Access | Times Cited: 2
Resveratrol‐Loaded Silver Nanoparticles as an Effective Strategy for Targeted Breast Cancer Therapy
Nur Eda Topçu, Ceylan Hepokur, İ. Afşin Kari̇per, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access | Times Cited: 2
Insights into the role of melatonin on the reproductive system toxicity induced by bisphenol A: a systematic review of preclinical studies
Behnaz Bameri, Maryam Armandeh, Hamed Haghi‐Aminjan, et al.
Toxin Reviews (2024) Vol. 43, Iss. 1, pp. 137-156
Closed Access | Times Cited: 1
Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations
Hongpeng Zhang, Yanshu Li
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105432-105432
Closed Access | Times Cited: 1
Unveiling resveratrol's potential: Navigating the landscape of autoimmune diseases
Keshava Jetha, Arya Vyas, Ashutosh Tripathi, et al.
Deleted Journal (2024) Vol. 5, Iss. 2, pp. 200145-200145
Open Access | Times Cited: 1
Lactiplantibacillus plantarum ZJ316 alleviates the oxidative stress and cellular apoptosis via modulating Nrf2/HO-1 signaling pathway
Shiying Wu, Yongqiang Chen, Fangtong Wei, et al.
Journal of Functional Foods (2024) Vol. 121, pp. 106409-106409
Open Access | Times Cited: 1
Resveratrol enhances the antiliver cancer effect of cisplatin by targeting the cell membrane protein PLA2
Yu Gao, Zhanyi Yang, Akhilesh Kumar Bajpai, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 4, pp. 307-326
Open Access | Times Cited: 1
Resveratrol, Piceatannol, Curcumin, and Quercetin as Therapeutic Targets in Gastric Cancer—Mechanisms and Clinical Implications for Natural Products
Paulina Warias, Paulina Plewa, Agata Poniewierska-Baran
Molecules (2024) Vol. 30, Iss. 1, pp. 3-3
Open Access | Times Cited: 1
Immunomodulatory and chemopreventive effects of resveratrol on the digestive system cancers
M Djaldetti
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 9, pp. 1389-1399
Open Access
Targeting the lung tumor stroma: harnessing nanoparticles for effective therapeutic interventions
Shushu Zhang, Hui Wang
Journal of drug targeting (2024) Vol. 33, Iss. 1, pp. 60-86
Closed Access
Drug Combination Studies of Isoquinolinone AM12 with Curcumin or Quercetin: A New Combination Strategy to Synergistically Inhibit 20S Proteasome
Carla Di Chio, Santo Previti, Josè Starvaggi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10708-10708
Open Access
Ursolic acid in colorectal cancer: mechanisms, current status, challenges, and future research directions
Hongjian Zhang, Xiaoyu Zhang, Xijun Ma, et al.
Pharmacological Reports (2024)
Closed Access
Page 1

Scroll to top